Tokyo Tape
Sign in
← Medinet

Annual report

2370.TEDINET S100PT7B
Period2021-10-01 → 2022-09-30
Filed2022-12-15
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 92
MetricValuePeriodScopeSource row
Revenue¥634m2021-10-01 → 2022-09-30StandaloneNet sales
Revenue¥683m2020-10-01 → 2021-09-30StandaloneNet sales
Revenue¥783m2019-10-01 → 2020-09-30dStandaloneNet sales (5-year summary)
Revenue¥1.1bn2018-10-01 → 2019-09-30dStandaloneNet sales (5-year summary)
Revenue¥998m2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Revenue¥958m2017-10-01 → 2018-09-30dStandaloneNet sales (5-year summary)
Operating income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOperating income
Operating income−¥1.1bn2020-10-01 → 2021-09-30StandaloneOperating income
Ordinary income−¥1.3bn2021-10-01 → 2022-09-30StandaloneOrdinary income
Ordinary income−¥871m2020-10-01 → 2021-09-30StandaloneOrdinary income
Ordinary income−¥837m2019-10-01 → 2020-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥995m2018-10-01 → 2019-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥2.7bn2017-10-01 → 2018-09-30dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥1.2bn2021-10-01 → 2022-09-30StandaloneIncome before income taxes
Profit before tax−¥838m2020-10-01 → 2021-09-30StandaloneIncome before income taxes
Net income (owners)−¥3.0bn2017-10-01 → 2018-09-30dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥1.3bn2021-10-01 → 2022-09-30StandaloneProfit loss
Net income−¥843m2020-10-01 → 2021-09-30StandaloneProfit loss
Net income−¥842m2019-10-01 → 2020-09-30dStandaloneNet income loss (5-year summary)
Net income−¥795m2018-10-01 → 2019-09-30dStandaloneNet income loss (5-year summary)
Net income−¥3.1bn2017-10-01 → 2018-09-30dStandaloneNet income loss (5-year summary)
Total assets¥6.1bnat 2022-09-30StandaloneAssets
Total assets¥5.4bnat 2021-09-30StandaloneAssets
Total assets¥5.2bnat 2020-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.1bnat 2019-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total assets¥3.9bnat 2018-09-30dStandaloneTotal assets (5-year summary)
Total liabilities¥566mat 2022-09-30StandaloneLiabilities
Total liabilities¥475mat 2021-09-30StandaloneLiabilities
Net assets / equity¥5.5bnat 2022-09-30StandaloneNet assets
Net assets / equity¥4.9bnat 2021-09-30StandaloneNet assets
Net assets / equity¥4.8bnat 2020-09-30dStandaloneNet assets
Net assets / equity¥2.6bnat 2019-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2018-09-30dStandaloneNet assets (5-year summary)
Net assets / equity¥3.3bnat 2018-09-30dStandaloneNet assets (5-year summary)
Cash and deposits¥4.5bnat 2022-09-30StandaloneCash and deposits
Cash and deposits¥4.1bnat 2021-09-30StandaloneCash and deposits
Cash & equivalents¥4.5bnat 2022-09-30StandaloneCash and cash equivalents
Cash & equivalents¥4.1bnat 2021-09-30StandaloneCash and cash equivalents
Cash & equivalents¥3.6bnat 2020-09-30dStandaloneCash and cash equivalents
Cash & equivalents¥1.4bnat 2019-09-30dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥2.2bnat 2018-09-30dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥1.2bn2021-10-01 → 2022-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥975m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥633m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥938m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥2.5bn2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥20m2021-10-01 → 2022-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥344m2020-10-01 → 2021-09-30StandaloneNet cash provided by used in investment activities
Investing cash flow¥86m2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥50m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥154m2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.6bn2021-10-01 → 2022-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.1bn2020-10-01 → 2021-09-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥2.8bn2019-10-01 → 2020-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥90m2018-10-01 → 2019-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2017-10-01 → 2018-09-30dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-6.332021-10-01 → 2022-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-4.882020-10-01 → 2021-09-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.192019-10-01 → 2020-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-6.712018-10-01 → 2019-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-26.772017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.472017-10-01 → 2018-09-30dStandaloneBasic earnings loss per share (5-year summary)
Net assets per share¥26.03at 2022-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥27.31at 2021-09-30StandaloneNet assets per share (5-year summary)
Net assets per share¥29.6at 2020-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥21.1at 2019-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥27.56at 2018-09-30dStandaloneNet assets per share (5-year summary)
Net assets per share¥27.03at 2018-09-30dStandaloneNet assets per share (5-year summary)
Equity ratio90.7%at 2022-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.8%at 2021-09-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio90.7%at 2020-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2019-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.8%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
Equity ratio82.7%at 2018-09-30dStandaloneEquity to asset ratio (5-year summary)
ROE-24.1%2021-10-01 → 2022-09-30StandaloneRate of return on equity (5-year summary)
ROE-17.5%2020-10-01 → 2021-09-30StandaloneRate of return on equity (5-year summary)
ROE-23.0%2019-10-01 → 2020-09-30dStandaloneRate of return on equity (5-year summary)
ROE-27.7%2018-10-01 → 2019-09-30dStandaloneRate of return on equity (5-year summary)
ROE-70.0%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
ROE-72.2%2017-10-01 → 2018-09-30dStandaloneRate of return on equity (5-year summary)
Shares issued211,730,423at 2022-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued178,750,423at 2021-09-30StandaloneTotal number of issued shares (5-year summary)
Shares issued160,830,423at 2020-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued120,875,423at 2019-09-30dStandaloneTotal number of issued shares (5-year summary)
Shares issued118,230,423at 2018-09-30dStandaloneTotal number of issued shares (5-year summary)
Employees96at 2022-09-30StandaloneNumber of employees
Employees83at 2021-09-30StandaloneNumber of employees
Employees78at 2020-09-30dStandaloneNumber of employees
Employees76at 2019-09-30dStandaloneNumber of employees
Employees92at 2018-09-30dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 46
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2021-10-01 → 2022-09-30¥13m
Reconciling Itemsreconcilingdepreciation2021-10-01 → 2022-09-30¥22m
Reconciling Itemsreconcilingsegment assetsat 2022-09-30¥5.3bn
Reconciling Itemsreconcilingsegment profit2021-10-01 → 2022-09-30−¥518m
Cellular And Tissue Based Product Businessreportable segmentcapex2021-10-01 → 2022-09-30¥4m
Cellular And Tissue Based Product Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥28m
Cellular And Tissue Based Product Businessreportable segmentemployeesat 2022-09-3019 pure
Cellular And Tissue Based Product Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥221,000
Cellular And Tissue Based Product Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥221,000
Cellular And Tissue Based Product Businessreportable segmentsegment assetsat 2022-09-30¥147m
Cellular And Tissue Based Product Businessreportable segmentsegment profit2021-10-01 → 2022-09-30−¥582m
Contracted Cell Manufacturing Businessreportable segmentcapex2021-10-01 → 2022-09-30¥60m
Contracted Cell Manufacturing Businessreportable segmentdepreciation2021-10-01 → 2022-09-30¥56m
Contracted Cell Manufacturing Businessreportable segmentemployeesat 2022-09-3065 pure
Contracted Cell Manufacturing Businessreportable segmentrevenue2021-10-01 → 2022-09-30¥633m
Contracted Cell Manufacturing Businessreportable segmentrevenue external2021-10-01 → 2022-09-30¥633m
Contracted Cell Manufacturing Businessreportable segmentsegment assetsat 2022-09-30¥643m
Contracted Cell Manufacturing Businessreportable segmentsegment profit2021-10-01 → 2022-09-30−¥233m
—segment totalcapex2021-10-01 → 2022-09-30¥64m
—segment totaldepreciation2021-10-01 → 2022-09-30¥84m
—segment totalrevenue2021-10-01 → 2022-09-30¥634m
—segment totalrevenue external2021-10-01 → 2022-09-30¥634m
—segment totalsegment assetsat 2022-09-30¥790m
—segment totalsegment profit2021-10-01 → 2022-09-30−¥815m
Reconciling Itemsreconcilingcapex2020-10-01 → 2021-09-30¥8m
Reconciling Itemsreconcilingdepreciation2020-10-01 → 2021-09-30¥23m
Reconciling Itemsreconcilingsegment assetsat 2021-09-30¥4.6bn
Reconciling Itemsreconcilingsegment profit2020-10-01 → 2021-09-30−¥497m
Cellular And Tissue Based Product Businessreportable segmentcapex2020-10-01 → 2021-09-30¥7m
Cellular And Tissue Based Product Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥34m
Cellular And Tissue Based Product Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥206,000
Cellular And Tissue Based Product Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥206,000
Cellular And Tissue Based Product Businessreportable segmentsegment assetsat 2021-09-30¥157m
Cellular And Tissue Based Product Businessreportable segmentsegment profit2020-10-01 → 2021-09-30−¥451m
Contracted Cell Manufacturing Businessreportable segmentcapex2020-10-01 → 2021-09-30¥18m
Contracted Cell Manufacturing Businessreportable segmentdepreciation2020-10-01 → 2021-09-30¥58m
Contracted Cell Manufacturing Businessreportable segmentrevenue2020-10-01 → 2021-09-30¥683m
Contracted Cell Manufacturing Businessreportable segmentrevenue external2020-10-01 → 2021-09-30¥683m
Contracted Cell Manufacturing Businessreportable segmentsegment assetsat 2021-09-30¥666m
Contracted Cell Manufacturing Businessreportable segmentsegment profit2020-10-01 → 2021-09-30−¥132m
—segment totalcapex2020-10-01 → 2021-09-30¥25m
—segment totaldepreciation2020-10-01 → 2021-09-30¥92m
—segment totalrevenue2020-10-01 → 2021-09-30¥683m
—segment totalrevenue external2020-10-01 → 2021-09-30¥683m
—segment totalsegment assetsat 2021-09-30¥824m
—segment totalsegment profit2020-10-01 → 2021-09-30−¥583m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,053
ItemContextValueUnit
Retained earnings brought forwardPrior1YearInstant_NonConsolidatedMember-843396000JPY
Retained earnings brought forwardCurrentYearInstant_NonConsolidatedMember-2093633000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember-843396000JPY
Retained earningsCurrentYearInstant_NonConsolidatedMember-2093633000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember－JPY
Treasury stockCurrentYearInstant_NonConsolidatedMember-2000JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember4789323000JPY
Shareholders equityCurrentYearInstant_NonConsolidatedMember5158978000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember91636000JPY
Valuation difference on available for sale securitiesCurrentYearInstant_NonConsolidatedMember352946000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember91636000JPY
Valuation and translation adjustmentsCurrentYearInstant_NonConsolidatedMember352946000JPY
Subscription rights to sharesPrior1YearInstant_NonConsolidatedMember21766000JPY
Subscription rights to sharesCurrentYearInstant_NonConsolidatedMember－JPY
Net assetsPrior1YearInstant_NonConsolidatedMember4902726000JPY
Net assetsCurrentYearInstant_NonConsolidatedMember5511924000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember5377672000JPY
Liabilities and net assetsCurrentYearInstant_NonConsolidatedMember6078061000JPY
Net salesPrior1YearDuration_NonConsolidatedMember683033000JPY
Net salesCurrentYearDuration_NonConsolidatedMember633672000JPY
Cost of salesPrior1YearDuration_NonConsolidatedMember502617000JPY
Cost of salesCurrentYearDuration_NonConsolidatedMember505748000JPY
Gross profitPrior1YearDuration_NonConsolidatedMember180415000JPY
Gross profitCurrentYearDuration_NonConsolidatedMember127923000JPY
Selling general and administrative expensesPrior1YearDuration_NonConsolidatedMember1261064000JPY
Selling general and administrative expensesCurrentYearDuration_NonConsolidatedMember1461023000JPY
Operating incomePrior1YearDuration_NonConsolidatedMember-1080648000JPY
Operating incomeCurrentYearDuration_NonConsolidatedMember-1333099000JPY
Interest income noiPrior1YearDuration_NonConsolidatedMember6834000JPY
Interest income noiCurrentYearDuration_NonConsolidatedMember6790000JPY
Gain on investments in partnership noiPrior1YearDuration_NonConsolidatedMember206155000JPY
Gain on investments in partnership noiCurrentYearDuration_NonConsolidatedMember1766000JPY
Reversal of allowance for doubtful accounts noiPrior1YearDuration_NonConsolidatedMember5000000JPY
Reversal of allowance for doubtful accounts noiCurrentYearDuration_NonConsolidatedMember6200000JPY
Income for cancellation of manufacturing noiPrior1YearDuration_NonConsolidatedMember－JPY
Income for cancellation of manufacturing noiCurrentYearDuration_NonConsolidatedMember10225000JPY
Other noiPrior1YearDuration_NonConsolidatedMember3538000JPY
Other noiCurrentYearDuration_NonConsolidatedMember1724000JPY
Non operating incomePrior1YearDuration_NonConsolidatedMember221528000JPY
Non operating incomeCurrentYearDuration_NonConsolidatedMember26707000JPY
Interest expenses noePrior1YearDuration_NonConsolidatedMember289000JPY
Interest expenses noeCurrentYearDuration_NonConsolidatedMember98000JPY
Stock issuance cost noePrior1YearDuration_NonConsolidatedMember6908000JPY
Stock issuance cost noeCurrentYearDuration_NonConsolidatedMember7487000JPY
Bond issuance cost and warrant cost noePrior1YearDuration_NonConsolidatedMember4341000JPY
Bond issuance cost and warrant cost noeCurrentYearDuration_NonConsolidatedMember－JPY
Foreign exchange losses noePrior1YearDuration_NonConsolidatedMember67000JPY
Foreign exchange losses noeCurrentYearDuration_NonConsolidatedMember283000JPY
Other noePrior1YearDuration_NonConsolidatedMember－JPY
Other noeCurrentYearDuration_NonConsolidatedMember0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2021-09-30pass rounding
balance sheet identitynon_consolidated 2022-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-09-30pass
statement vs summary · net assetsnon_consolidated 2021-09-30pass
statement vs summary · net assetsnon_consolidated 2022-09-30pass
statement vs summary · operating cash flownon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · operating cash flownon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · revenuenon_consolidated 2020-10-01/2021-09-30pass
statement vs summary · revenuenon_consolidated 2021-10-01/2022-09-30pass
statement vs summary · total assetsnon_consolidated 2021-09-30pass
statement vs summary · total assetsnon_consolidated 2022-09-30pass